Teaching Adolescents with Type 1 Diabetes Self-compassion
TADS
1 other identifier
interventional
141
1 country
1
Brief Summary
The purpose of this study is to see if a mindful self-compassion program given virtually can improve emotional distress for youth with type 1 diabetes, compared to routine care as usual.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Oct 2022
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 12, 2022
CompletedFirst Posted
Study publicly available on registry
July 19, 2022
CompletedStudy Start
First participant enrolled
October 4, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2024
CompletedFebruary 18, 2025
February 1, 2025
5 months
July 12, 2022
February 14, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Diabetes Distress as measured by the Problem Areas in Diabetes - Teen Version (PAID-T)
Diabetes distress as measured by the PAID-T will be compared in those who complete the MSC program to those in the wait-list control group at 3 months. Scores can range from 26-156, with scores of \<70, 70-90, and \>90 representing none-to-mild, moderate, and severe diabetes distress, respectively.
3 months
Secondary Outcomes (5)
Anxiety as measured by the Generalized Anxiety 7-item scale (GAD-7)
3 months, 12 months
Depression as measured by the Patient Health Questionnaire (PHQ-9)
3 months, 12 months
Disordered eating as measured by the Diabetes Eating Problem Survey, revised version (DEPS-R)
3 months, 12 months
Suicidal ideation as measured by the Patient Health Questionnaire (PHQ-9)
3 months, 12 months
Diabetes distress as measured by the Problem Areas in Diabetes - Teen version (PAID-T)
12 months
Other Outcomes (3)
Interaction term of time and diabetes distress
Baseline, 8 weeks, 3 months, 6 months, 12 months
Hemoglobin A1c
Baseline, 12 months
Time in Range
Baseline, 8 weeks, 3 months, 6 months, 12 months
Study Arms (2)
Mindful Self-Compassion Arm
EXPERIMENTALParticipants in this arm will participate in an 8-week virtual mindful self-compassion program.
Wait-list Control Arm
NO INTERVENTIONParticipants in this arm will receive usual clinical care and will have the opportunity to participate in the mindful self-compassion program at the end of the study.
Interventions
The intervention consists of 8 sessions, one per week for 8 weeks, that last 1 hour and 30 minutes each. These sessions will cover a variety of mindfulness and self-compassion practices, such as dealing with difficult emotions and developing a kind inner voice.
Eligibility Criteria
You may qualify if:
- Between 12-17 years of age
- Diagnosed with type 1 diabetes at least 6 months prior to enrollment
- Able to provide informed consent
You may not qualify if:
- Unable or unwilling to provide informed consent
- Do not speak English or French with enough fluency to complete all study related tasks
- Presence of an intellectual disability that would preclude participation in the MSC intervention, as assessed by the treating physician
- Lifetime diagnosis of a serious mental illness given by a clinician (e.g., psychotic or bipolar disorders), as these often involve intensive treatments with psychological and/or pharmacologic implications, which may confound our results.
- Presence of acute suicidality at the time of enrollment (if a patient reports suicidality on the baseline questionnaires, a same-day assessment will be conducted to assess for acute suicidality. If present, the patient will receive immediate clinical attention and will no longer be eligible to participate in the study).
- Active participation in another mental health intervention trial.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Children's Hospital of Eastern Ontariolead
- Juvenile Diabetes Research Foundationcollaborator
- Brain Canadacollaborator
Study Sites (1)
Children's Hospital of Eastern Ontario
Ottawa, Ontatrio, K1H8L1, Canada
Related Publications (1)
Dover S, Ahmet A, Bluth K, Feldman BM, Goldbloom EB, Goldfield GS, Hamilton S, Imran O, Khalif A, Khatchadourian K, Lawrence S, Leonard A, Liu K, Ouyang Y, Peeters C, Shah J, Spector N, Zuijdwijk C, Robinson ME. Teaching Adolescents With Type 1 Diabetes Self-Compassion (TADS) to Reduce Diabetes Distress: Protocol for a Randomized Controlled Trial. JMIR Res Protoc. 2023 Dec 26;12:e53935. doi: 10.2196/53935.
PMID: 38048480DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Marie-Eve Robinson, MD, MSc
Children's Hospital of Eastern Ontario
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
July 12, 2022
First Posted
July 19, 2022
Study Start
October 4, 2022
Primary Completion
March 1, 2023
Study Completion
April 1, 2024
Last Updated
February 18, 2025
Record last verified: 2025-02
Data Sharing
- IPD Sharing
- Will not share
IPD will be made available upon reasonable request from other researchers.